Endoscopic Pancreatic Sphincterotomy: Indications and Complications by Joo, Yong Won et al.
Endoscopic Pancreatic Sphincterotomy: Indications and
Complications
Yong Won Joo, Jai Hoon Yoon, Seung Chul Cho, Kang Nyeong Lee, Na Rae Ha, Hang Lak Lee, Oh Young Lee, 
Byung Chul Yoon, Ho Soon Choi, Joon Soo Hahm, Dong Hoo Lee, and Min Ho Lee
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
DOI: 10.3904/kjim.2009.24.3.190
ORIGINAL ARTICLE
Background/Aims: Although a few recent studies have reported the effectiveness of endoscopic pancreatic
sphincterotomy (EPST), none has compared physicians’ skills and complications resulting from the procedure.
Thus, we examined the indications, complications, and safety of EPST performed by a single physician at a single
center.
Methods: Among 2,313 patients who underwent endoscopic retrograde cholangiopancreatography between
January 1996 and March 2008, 46 patients who underwent EPST were included in this retrospective study. We
examined the indications, complications, safety, and effectiveness of EPST, as well as the need for a pancreatic
drainage procedure and the concomitant application of EPST and endoscopic sphincterotomy (EST).  
Results: Diagnostic indications for EPST were chronic pancreatitis (26 cases), pancreatic divisum (4 cases), and
pancreatic cancer (8 cases). Therapeutic indications for EPST were removal of a pancreaticolith (10 cases), stent
insertion for pancreatic duct stenosis (9 cases), nasopancreatic drainage (7 cases), and treatment of sphincter of
Oddi dysfunction (1 case). The success rate of EPST was 95.7% (44/46). Acute complications of EPST included
five cases (10.9%) of pancreatitis and one of cholangitis (2.2%). EPST with EST did not reduce biliary complications.
Endoscopic pancreatic drainage procedures following EPST did not reduce pancreatic complications.
Conclusions: EPST showed a low incidence of complications and a high rate of treatment success; thus, EPST
is a relatively safe procedure that can be used to treat pancreatic diseases. Pancreatic drainage procedures and
additional EST following EPST did not reduce the incidence of procedure-related complications. (Korean J Intern
Med 2009;24:190-195)
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INTRODUCTION
Anatomically, the sphincter of Oddi is divided primarily
into the bile duct sphincter located in the distal common
bile duct, the pancreatic duct sphincter forming the distal
pancreatic duct, and the ampullary sphincter, which is
present in the common bile duct and the common pan-
creatic duct. In endoscopic sphincterotomy (EST), only
the ampullary sphincter and bile duct sphincter are
resected, while the pancreatic sphincter is left intact [1]. In
the clinical setting, EST was first used in 1974 by Kawai in
Japan and Classen in Germany. Since then, its safety and
effectiveness have been demonstrated and it is acknowl-
edged as an important procedure in the diagnosis and
treatment of biliary disease [2].
Endoscopic pancreatic sphincterotomy (EPST) was
first described by Fuji et al. in 1976. Because of its technical
difficulty and complications, however, its use has been
restricted in the clinical field [3]. Because of this, the
methods, indications, and safety of EPST have not been
established. Various proposals have been made as to
whether EST or EPST should be performed first [4-8].Joo YW, et al. Endoscopic pancreatic sphincterotomy   191
Elton et al. reported that the use of a pancreatic stent and
endoscopic nasopancreatic drainage (ENPD) following
EPST could reduce the incidence of complications [9].
According to other studies, however, the usefulness of
ENPD is questionable [10]. Very few recent studies [10]
have reported on the safety and complications of EPST
performed by a single physician at a single center.
We examined the indications, complications, and safety
of EPST, and compared the incidence of complications
in cases when a pancreatic drainage procedure was per-
formed. In particular, we compared procedures in which
EST following EPST was performed and those in which
EPST was performed alone.
METHODS
Patients
Of 2,313 patients who underwent endoscopic retrograde
cholangiopancreatography (ERCP) at Hanyang University
Medical Center between January 1996 and March 2008,
46 patients who underwent EPST were enrolled. These
patients consisted of 39 men and 7 women (mean age 54.6
and 52.4 years, respectively; Table 1).
Methods
EPST was performed for either the main pancreatic
duct or the accessory pancreatic duct, or for the main
pancreatic duct together with the accessory pancreatic
duct. For endoscopy, a duodenoscopy was performed.
Based on the location and type of orifice, the incision was
made using a cutting and coagulation blended current,
with a standard pull-type papillotome or needle knife.
During the EPST procedure, midazolam, pethidine, and
Buscopan were intravenously infused as needed. For main
pancreatic sphincterotomy, a 5-10 mm incision was made
in a 12-2 o’clock direction, along the axis of the main
pancreatic duct from the opening of the pancreatic duct.
An incision was made up to the upper margin of the hood-
ing fold [11]. For accessory pancreatic duct incisions, the
location of the accessory pancreatic duct was confirmed
using a specialized catheter. The incision was attempted
by inserting a papillotome using a 0.018-inch guidewire.
Otherwise, the incision was made using a needle knife
papillotome [11]. In patients with severe pancreatic stenosis,
a pancreatic stent and ENPD were inserted, if necessary.
All patients were given a full explanation about the pro-
cedure and provided written informed consent.
Treatment success in EPST was defined as cases in
which the opening of the pancreas could be successfully
approached following the procedure. Pancreatitis was
defined as cases in which serum amylase exceeded three
times the normal value in the presence of epigastric pain,
even 24 hours after the procedure. Bleeding was defined
as cases in which a blood transfusion was carried out after
hemoglobin decreased by more than 2 g/dL within a day
after the procedure. The definitions and severity of other
complications were based on the classification system of
Cotton et al. [12]
Statistical analysis
Statistical analyses were performed using SPSS for
windows, version 12.0 (SPSS inc., Chicago, IL, USA). A
cross-tabulation was carried out using the chi-square test
and the Mann-Whitney U-test. P values <0.05 were
deemed to be statistically significant. 
RESULTS
In the 46 patients, the success rate of EPST was 95.7%
(44/46). Two cases of failure occurred, both in accessory
pancreatic duct dissections. A main pancreatic sphinc-
terotomy was performed in 42 cases (91.3%), while an
accessory pancreatic sphincterotomy was carried out in
four cases (8.7%, Table 1). The causative factors for
chronic pancreatitis requiring EPST involved alcoholism
(63%) and unknown causes (21%). Anatomical anomalies,
such as anomalous union of the pancreaticobiliary duct
(AUPBD) and pancreatic divisum, accounted for the other
16% (data not shown).
Indications for EPST
The most frequent diagnostic indication (26 cases)
Table 1. Demographic characteristics of the patients
Characteristics Number of patients
Male/female, n 39/7
Mean age, years (range) 54.2 (29-77)
EPST alone/EPST with EST, n (%) 19 (41.3)/27 (58.7)
Location of EPST, n (%)
Major papilla  42 (91.0)
Minor papilla 4 (9.0)
Successful EPST, n (%) 44 (95.7)
EPST, endoscopic pancreatic sphincterotomy; EST, endoscopic
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was chronic pancreatitis, with or without concurrent
pancreaticolith and dilatation of the pancreatic duct.
Eight cases occurred in which the procedure was per-
formed to biopsy the pancreatic duct and to inspect it on
suspicion of pancreatic cancer. In two cases, the procedure
was performed to assess intraductal papillary mucinous
neoplasm (IPMN) within the pancreatic duct. In four
cases, the procedure was carried out to diagnose and treat
pancreatic divisum. In three cases, the procedure was
conducted to diagnose and treat a pancreatic pseudocyst.
In one case, the procedure was performed because of
sphincter of Oddi dysfunction (SOD). In one case, the
procedure was performed because of the AUPBD and a
choledochal cyst, and in one case because of restenosis
of the pancreatic duct. The number of patients who
underwent EPST alone was 18 (38.1%), while the number
of patients who underwent EPST concomitantly with EST
was 28 (60.9%). The number of patients who underwent
pancreatic drainage procedure following EPST was 19
(41.3%), and the number of patients who did not undergo
any pancreatic drainage procedure was 27 (58.7%, Table 2).
In terms of therapeutic indication, EPST was performed
for pancreaticolith removal in ten cases, the insertion
of a stent in a stenotic lesion in nine cases, endoscopic
nasopancreatic duct drainage in seven cases, the insertion
of a pancreatic stent for the treatment of pancreatic
pseudocysts in three cases, and the treatment of SOD in
one case (Table 3).
Complications of EPST
Acute complications, which occurred following EPST,
included five cases (10.9%) of pancreatitis and one of
cholangitis (2.2%). Severe complications found in the
literature, such as bleeding, perforation, pancreatic duct
rupture, and sepsis, for which the hospitalization period
was prolonged, did not occur. Eight cases of hyperamy-
lasemia were observed that were not clinically notable,
and one case of bleeding in which hemostasis was
attempted by injecting epinephrine at the site where
EPST was performed. Complications developed in two
cases (7.1%, 2/28) in which EPST with EST and four cases
(22.2%, 4/18) in which EPST alone was performed;
however, this difference was not statistically significant
(p=0.19). Laboratory findings were compared before and
after the procedure between the groups in which EPST
with EST and EPST alone were performed. Mean total
bilirubin was higher in the group in which EPST with EST
Table 2. Diagnostic indications for EPST
Indications Total Without EST With EST Without drain With drain
(n=46) (n=18) (n=28) (n=27) (n=19)
Chronic pancreatitis
Major papilla 25 13 12 12 13
Minor papilla 1 0 1 1 0
Pancreatic  pseudocyst 3 1 2 0 3
Pancreatic divisum
Major papilla 1 0 1 1 0
Minor papilla 3 1 2 3 1
Pancreatic cancer 8 1 7 7 1
IPMN of the pancreas 2 2 0 2 0
SOD-p type 1 0 1 1 0
AUPBD with choledocal cyst 1 0 1 1 0
Restenosis of EPST 1 0 1 0 1
EPST, endoscopic pancreatic sphincterotomy; EST, endoscopic biliary sphincterotomy; IPMN, intraductal papillary mucinous
neoplasm; SOD-p type, sphincter of Oddi dysfunction (pancreatic type); AUPBD, anomalous union of the pancreaticobiliary duct.
Table  3. Therapeutic indications for EPST
Indications                                                       Number of patients 
Chronic pancreatitis 
Removal of pancreaticoliths 10
Stents for pancreatic duct strictures 7
Endoscopic nasopancreatic drainage 7
Pancreas divisum 
Stent for pancreatic duct stricture 2
Endoscopic nasopancreatic drainage 1
Transpapillary stent for pancreatic pseudocyst 3
Sphincter of Oddi dysfunction (pancreatic type) 1
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was performed versus the group in which EPST alone was
performed (3.1 mg/dL vs. 0.8 mg/dL, respectively;
p=0.36). Mean alkaline phosphatase was also higher in
the group in which EPST with EST was performed versus
the group in which EPST alone was performed (337.6 U/L
vs. 101.5 U/L, respectively; p=0.35). In other laboratory
findings, differences were not statistically significant
(Table 4).
The incidence of complications was 17.6% (3/17) in
cases in which pancreatic drainage was performed and
10.3% (3/29) in other cases. This difference was not
statistically significant (p=0.66; data not shown). In
cases in which complications occurred, the symptoms
were improved only by medical treatments. In no case was
the hospitalization prolonged, and no death occurred. Of
the 46 subjects, follow-up observations were available for
34 patients. In these patients, the mean follow-up period
was 62.6 months (range, 1-132 months). The only late-
stage complication associated with EPST was one case of
restenosis of the pancreatic duct, which developed after 38
months (2.1%, 1/46).
DISCUSSION
EST has been used for treatment since the 1970s, and is
acknowledged as a relatively safe procedure based on
studies reporting that the early complication rate was
about 10% and the mortality rate was about 1%. In
contrast, EPST was introduced to the clinical setting
about 10 years later in the 1980s [10]. In recent years,
the clinical indications of EPST have become more
widely accepted, but due to the low frequency of the
procedure and procedure-related complications, no
standard treatment regimen has been established. Elton
et al. proposed that EPST be used for the diagnosis and
treatment of various pancreatic diseases, such as SOD,
chronic pancreatitis, pancreatic pseudocysts, pancreatic
divisum, papillary adenoma, pancreatic cancer, and
pancreatic fistula [9]. EPST makes it easier to approach
the pancreatic duct to insert a pancreatic stent, remove
a pancreatolith, and biopsy tissue from a pancreatic
stenosis. It is also used in the treatment of pancreatic
sphincter dysfunction. As described here, EPST is a useful
procedure, together with pancreatic drainage, for the
diagnosis and treatment of pancreatic diseases. However,
because of operator concern regarding technical difficulties
and the occurrence of complications, EPST is not performed
as frequently as EST [13].
The incidence of complications following EPST is
similar to that following EST. Early-stage complications
include pancreatitis, bleeding, duodenal perforation,
and cholangitis [10-15]. The incidence of complications
following EPST has been reported to be 3.2% to 15.7%
(mean, 13.6%). In the current study, we made a comparison
of other reports on the incidence of severe complications
for which hospitalization was prolonged or treatment was
needed, excluding mild complications requiring no
treatment [11,13,15]. This analysis showed no difference in
the incidence of complications or their severity following
EPST. Most of the complications were dealt with by con-
servative management only. In no case was the treatment
period prolonged or any additional procedure or surgery
needed due to the occurrence of a procedurerelated com-
plication, such as severe bleeding, pancreatitis, or per-
foration. Thus, we conclude that EPST is a relatively safe
procedure, and the incidence of complications due to its
technical difficulty was actually lower than for EST.
EPST is a single procedure, but it is rarely used alone
in diagnosis or treatment. In many cases, it is used con-
comitantly with other procedures, such as the removal of
pancreaticoliths, the insertion of pancreatic stents, and the
dilatation of pancreatic stenosis. Therefore, symptoms
deemed to be complications of EPST cannot be stated to
Table 4. Biliary complications: EPST alone vs. EPST with EST
Without EST With EST p value
(n=20) (n=26)
Difference of bilirubin, mg/dL 1.9±5.8 1.0±2.9 0.96
Difference of ALP, U/L  65.6±150.3 117.0±296.3 0.43
Difference of WBC, /mm
3 565±3,463 3,049±5,051 0.41
CBD dilatation, n 3 8 0.38
Cholangitis, n 0 1 0.21
ENBD, n 0 6 0.02
EPST, endoscopic pancreatic sphincterotomy; EST, endoscopic biliary sphincterotomy; ALP, alkaline phosphatase; CBD, common bile
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have originated solely or directly from EPST. Jacobs et al.
[10] conducted a long-term follow-up study at a single
institution (n=171, 18-124 months) and reported that the
reprocedure rate due to findings such as restenosis was
9.9% (17/167) after a mean period of 7 months (range 0.5-
36 months). In the current study, however, late comp-
lications were noted in 2.1% (1/46) of the cases, a
considerably smaller number. These results may have
originated from selection bias due to the small number of
enrolled patients and because many were lost to follow-
up (12/46, 26%). Slight differences in the incidence of
complications seen in other studies may also have been
due to the heterogeneous characteristics of the subjects.
In the current study, a single investigator performed the
procedure at a single institution and conducted the follow-
up study. The results showed that EPST did not cause late
complications requiring treatment. The success rate for
EPST was 95.7% (44/46), similar to that reported in other
studies; thus, EPST was considered to be a relatively safe
procedure. This might not have been attributable to EPST
being a technically simple procedure, but occurred because
many experts who have experience in EST preferentially
attempt to use EPST. In other words, when physicians
carry out endoscopic therapy at the pancreatic duct, they
are already experienced and can thus be expected to have
lower complication rates.
Various proposals have been made regarding whether
EST or EPST should be preformed first. A theoretical basis
for the concomitant use of EST with EPST is that the
swelling of the opening of ampulla can cause bile duct
stenosis and cholangitis due to thermal injury resulting
from the EPST procedure [4,5]. Therefore, the cutting
wave, rather than the coagulation wave, is recommended
to be used more frequently [6]. In the group in which EPST
followed EST versus the group in which EST was preceded
by EPST, this is advantageous in that a papillotome could
be readily inserted and the scope of the EPST incision
could be accurately measured because the opening of the
pancreatic duct could be clearly disclosed [6,13]. Fuji et al.
stated that the reason for the preceding use of EPST is
that determining the scope of the incision is difficult due
to damage to the hooding fold in cases when EST is per-
formed first [7]. Recent randomized controlled trials have
shown that EST is not an essential procedure, but that
the procedure should be determined based on the status
of bile duct prior to the procedure in cases in which EPST
is needed [8]. In the current study, the incidence of
complications was similar between the group with EPST
alone and the group experiencing EPST with EST. The
incidence of complications was not lower in the EPST
with EST group compared to the EPST-alone group. As
described here, the reason why no significant difference
was detected in the incidence of complications may have
been due to selection bias occurring in such cases; the
comparison was based on the same patient condition not
being present between the EPST with EST group and the
EPST-alone group and patients who concurrently had
biliary disease prior to the procedure being included in the
EPST with EST group.
Various opinions exist regarding the incidence of
complications following pancreatic drainage and the
rationale for it. Elton et al. reported that the insertion
of pancreatic duct or nasopancreatic drainage could
reduce acute complications [9]. Through an analysis of
572 cases of EPST, Hookey et al. maintained that pancre-
atic drainage was needed to lower the intrapancreatic
pressure generated by papillary edema following EPST
[16]. This view has been challenged, however, and many
negative opinions exist regarding whether nasopancreatic
drainage does indeed reduce complications [10,17]. In
contrast, pancreatic drainage has been reported to reduce
the occurrence of acute complications in some cases,
including SOD [9,15].
However, in the current study, no significant difference
was found in the incidence of complications between the
group in which pancreatic drainage was performed and
the group in which it was not. In contrast, the occurrence
of hyperamylasemia increased in the group in which
pancreatic drainage was performed. These findings may
be the result of stimulation of the pancreatic duct due to
the insertion of a pancreatic stent or nasopancreatic
drainage in severe pancreatic stenosis or cases in which a
small pancreaticolith was present.  Indications for EPST in
the current study included chronic pancreatic diseases,
such as chronic pancreatitis, pancreatic cancer, and
pancreatic divisum. In fact, the incidence of complications
apparently increased following pancreatic drainage. Of
the indications in the current study, the usefulness of
pancreatic drainage following papillectomy could not
be statistically evaluated because of the small number
of enrolled patients. 
Other limitations of the current study include the
following: (1) The current study was designed as a
retrospective analysis and this may have caused selection
bias, leading to statistical error. (2) The follow-up period
was substantial. Due to the small number of enrolledJoo YW, et al. Endoscopic pancreatic sphincterotomy   195
patients, however, the current study could not reflect
demographic characteristics such as age and gender. For
example, the current study could not consider risk factors
in a high-risk group of patients in whom complications
such as pancreatitis can occur. (3) Some patients were lost
during the follow-up period, which lowered the reliability
of the statistical analysis of late complications.
Despite these limitations, because the current study was
conducted by a single investigator at a single institution,
the consistency of the treatment procedure was high and
its correlation with the complications occurring following
EPST could be established. 
In conclusion, the current study showed that EPST is a
relatively safe procedure, with a high success rate, and
that it can be used for the diagnosis and treatment of
pancreatic diseases. EPST showed a lower incidence of
complications and a higher rate of treatment success;
thus, EPST is a relatively safe procedure that can be used
to treat pancreatic disease. Additionally, performing EST
after EPST is not always necessary. Pancreatic drainage
following EPST did not reduce the incidence of procedur-
erelated complications in this study. Pancreatic stimulation
due to the procedure can cause mild complications. Further
larger-scale, prospective studies are warranted to deter-
mine the risk factors for developing complications.
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